The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with ALL treated by ALL-BFM 90 protocol

Electronic Journal of Oncology

Volumn , Issue 1, 1999, Pages 80-89

  Mihal, Vladimir ^a   Hajduch, Marian ^a   Noskova, Vera ^a   Janostakova, Anna ^a   Safarova, Maria ^a   Orel, Miroslav ^a   Kouzmina, Galina ^a   Stary, Jan ^b   Blazek, Bohuslav ^c   Pospisilova, Dagmar ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Department of Pediatrics ^*  (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; ETOPOSIDE; GLUCOCORTICOID; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLAST CELL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LABORATORY TEST; LEUKEMIA CELL; LEUKOCYTE COUNT; MALE; MONOTHERAPY; PATIENT MONITORING; REGULATORY MECHANISM; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 0006086697     PISSN: 12928933     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Farber, S., Diamond, L.K., Mercer, R.D. and Sylvester, R.F. Temporary remission in acute leukemia children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New Engl. J. Med., 238: 787-794, 1948.
2. Ribero, R.C. and Pui, C.-H. Prognostic factors in childhood acute lymphoblastic leukemia. Hematol. Pathol., 7: 121-142, 1993.
3. Rivera, G.K., Pinkel, D., Simone, J.V., Hancock, M.L. and Crist, W.M. Treatment of acute lymphoblastic leukemia. 30-years experience at St. Jude Childrens Research Hospital. New Engl. J. Med., 329: 1290-1301, 1993.
4. Henze, G., Aghte, A.G., Neuendank, A., Hartmann, R., Dorfell, W., Bruhmuller, S., Klumper, E., Pieters, R. and Veerman, A.J.P. Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia. Leukemia, 9: 538, 1995.
5. Pieters, R., Huismans, D.R., Loonen, A.H., Haglen, K., Van Der Does-Van Den Berg, A., Van Wering, E.R. and Veerman, A.J.P. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukemia. Lancet, 338: 399-403, 1991.
6. Ritter, J., Creutzig, U., Reiter, A., Riehm, H. and Schelling, G. Childhood leukemia: cooperative Berlin-Frankfurt-Munster trials in the Federal Republic of Germany. J Cancer Res. Clin. Oncol., 116: 100, 1990.
7. Hajduch, M., Mihal, V., Minarik, J., Faber, E., Safarova, M., Weigl, E. and Antalek, P. Decreased in vitro chemosensitivity of tumor cells in patients suffering from malignant diseases with poor prognosis. Cytotechnology, 19: 243-245, 1996.
8. Pieters, R., Huismans, D.R., Leyva, A. and Veerman, A.J.P. Adaptation of the rapid automated tetrazolium day based (MTT-) assay for chemosensitivity testing in childhood leukemia. Cancer Lett., 41: 323-332, 1988.
9. Bird, M.C., Bosanquet, A.G., Forskitt, S. and Gilby, E.G. Long term comparison of results of an in vitro drug sensitivity assay with patient response in lymphatic neoplasms. Cancer, 61: 1004, 1988.
10. Santini, V., Bernabei, P.A., Silvestro, L., Dal Pozzo, O., Bezzini, R., Viano, I., Gattei, V., Saccardi, R. and Rossi Ferrini, O. In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with non-lymphocytic leukemia. Hematol. Oncol., 7: 287, 1989.
11. Pieters, R., Huismans, D.R., Loonen, A.H. and Veerman, A.J.P. Relation of cellular drug resistance to long-term clinical outcome in childhood acute leukemia. Lancet, 338: 399-403, 1991.
12. Maung, Z.T., Reid, M., Matheson, E., Taylor, P.R.A., Proctor, S.J., Hall, A.G. Corticoid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukemia. Br. J. Hematol., 91: 93-100, 1995.
13. Masson, E., Synoid, T.W., Reiling, M.W., Schuetz, J.D., Sandlund, J.T., Pui, C.H. and Evans, W.E. Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute lymphoblastic leukemia. Leukemia, 10: 56-60, 1996.
14. Simpson, A.J. The natural somatic mutation frequency and human carcinogenesis. Adv. Cancer. Res., 71: 209-40, 1997.
15. Beck, W.T. and Danks, M.K. Altered surface membrane glycoproteins in Vinca alkaloid resistant human leukemic lymphoblasts. Cancer Res., 39: 2070-2076, 1979.
16. Danks, M.K., Yalowich, J.C. and Beck, W.T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide. Cancer Res., 47: 1297-1301, 1987.
17. Hongo, T., Yajima, S., and Sakurai, M. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood, 89: 2959-2965, 1997.